Skip to main content

FDA Updates

Nivolumab First Immunotherapy Approved for Adjuvant Treatment of Urothelial Carcinoma

Jemperli Another Therapy Approved for Patients with dMMR Recurrent or Advanced Solid Tumors

Lenvima plus Keytruda a New Combination Approved for Advanced Renal-Cell Carcinoma

Pylarify Second Radioactive Imaging Drug FDA Approved for PSMA-Positive Prostate Cancer

Truseltiq (Infigratinib) New Targeted Therapy FDA Approved for Advanced or Metastatic Cholangiocarcinoma Harboring FGFR2 Alterations

Loretta Fala, Medical Writer

Rylaze FDA Approved as Part of a Treatment Regimen for Pediatric Leukemia and Lymphoma

FDA Approved Truseltiq for Metastatic Cholangiocarcinoma with the FGFR2 Biomarker

FDA Approves Darzalex Faspro plus Pomalyst and Dexamethasone for Multiple Myeloma

FDA Approves Avapritinib for Advanced Systemic Mastocytosis

Pembrolizumab plus Lenvatinib Combination Receives Regular Approval for Advanced Endometrial Carcinoma

8
9
10
11
12
13
14

Page 11 of 33
Results 101 - 110 of 330